SNT Quarterly Shareholder Update - June 2019 25/07/19 PRICE SENSITIVE download Created with Sketch. 395.58KB Share SNT Appendix 4C - quarterly 25/07/19 PRICE SENSITIVE download Created with Sketch. 120.79KB Share SNT Pathway to US Bronchitol Approval Clarified in FDA Response 20/06/19 PRICE SENSITIVE download Created with Sketch. 103.01KB Share SNT US Advisory Committee Positive Recommendation on Bronchitol 09/05/19 PRICE SENSITIVE download Created with Sketch. 134.45KB Share SNT Quarterly Shareholder Update - March 2019 29/04/19 PRICE SENSITIVE download Created with Sketch. 390.02KB Share SNT Appendix 4C - quarterly 29/04/19 PRICE SENSITIVE download Created with Sketch. 123.23KB Share SNT Pharmaxis Commences Phase 1 LOX Clinical Trial 22/02/19 PRICE SENSITIVE download Created with Sketch. 128.88KB Share SNT Half Yearly Report and Accounts 14/02/19 PRICE SENSITIVE download Created with Sketch. 553.93KB Share SNT Quarterly Shareholder Update - December 2018 30/01/19 PRICE SENSITIVE download Created with Sketch. 385.27KB Share SNT Appendix 4C - quarterly 30/01/19 PRICE SENSITIVE download Created with Sketch. 120.71KB Share SNT Pharmaxis Announces LOXL2 Program Phase 2 Ready 17/01/19 PRICE SENSITIVE download Created with Sketch. 116.23KB Share SNT PHARMAXIS ANNOUNCES RESUBMISSION OF BRONCHITOL NDA IN USA 20/12/18 PRICE SENSITIVE download Created with Sketch. 114.21KB Share SNT Pharmaxis Announces First Relaunch Sales of Aridol in USA 13/12/18 PRICE SENSITIVE download Created with Sketch. 116.72KB Share SNT Pharmaxis AGM - CEO Presentation 22/11/18 PRICE SENSITIVE download Created with Sketch. 1.17MB Share SNT Chairman's Address to Shareholders 22/11/18 PRICE SENSITIVE download Created with Sketch. 108.27KB Share SNT LOX Inhibitor Program for Pancreatic Cancer Phase 1 Ready 20/11/18 PRICE SENSITIVE download Created with Sketch. 146.6KB Share SNT Pharmaxis Releases Positive Results of Phase 1 Clinical Tria 15/11/18 PRICE SENSITIVE download Created with Sketch. 117.37KB Share SNT Appendix 4C - quarterly 26/10/18 PRICE SENSITIVE download Created with Sketch. 122.69KB Share SNT Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor 11/10/18 PRICE SENSITIVE download Created with Sketch. 117.56KB Share SNT Preliminary Final Report 17/08/18 PRICE SENSITIVE download Created with Sketch. 921.26KB Share SNT FDA Factory Approval and Relaunch of Aridol in US Market 15/08/18 PRICE SENSITIVE download Created with Sketch. 124.73KB Share SNT Capital Raising Presentation 06/08/18 PRICE SENSITIVE download Created with Sketch. 1.27MB Share SNT Pharmaxis Announces A$24m Placement 06/08/18 PRICE SENSITIVE download Created with Sketch. 127.66KB Share SNT Trading Halt Announcement - System Upgrade 06/08/18 PRICE SENSITIVE download Created with Sketch. 220.36KB Share SNT Trading Halt 03/08/18 PRICE SENSITIVE download Created with Sketch. 271.05KB Share SNT Quarterly Shareholder Update - June 2018 27/07/18 PRICE SENSITIVE download Created with Sketch. 441.24KB Share SNT Appendix 4C - quarterly 27/07/18 PRICE SENSITIVE download Created with Sketch. 122.6KB Share SNT LOXL2 Program Attracts Strong Partner Interest at BIO18 14/06/18 PRICE SENSITIVE download Created with Sketch. 120.63KB Share SNT Quarterly Shareholder Update - March 2018 30/04/18 PRICE SENSITIVE download Created with Sketch. 375.62KB Share SNT Appendix 4C - quarterly 30/04/18 PRICE SENSITIVE download Created with Sketch. 194.74KB Share SNT Half Yearly Report and Accounts 15/02/18 PRICE SENSITIVE download Created with Sketch. 241.7KB Share SNT Appendix 4C - quarterly 29/01/18 PRICE SENSITIVE download Created with Sketch. 122.57KB Share SNT Pharmaxis Earns A$15 Million Milestone Payment 11/01/18 PRICE SENSITIVE download Created with Sketch. 162.61KB Share SNT New Australian PBS Listing for Brocnhitol 02/01/18 PRICE SENSITIVE download Created with Sketch. 151.78KB Share SNT Pharmaxis Acquires Control, Increases Stake in LOXL2 Program 14/12/17 PRICE SENSITIVE download Created with Sketch. 161.14KB Share SNT Appendix 4C - quarterly 27/10/17 PRICE SENSITIVE download Created with Sketch. 121.88KB Share SNT Boehringer Initiating Phase 2a Study Diabetic Retinopathy 08/09/17 PRICE SENSITIVE download Created with Sketch. 114.55KB Share SNT Antifibrotic LOXL2 Program Clears Preclinical Development 06/09/17 PRICE SENSITIVE download Created with Sketch. 123.16KB Share SNT Boehringer Ingelheim Initiates Phase IIa Study in NASH 25/08/17 PRICE SENSITIVE download Created with Sketch. 114.67KB Share SNT Positive Recommendation for Broader Bronchitol Access in Aus 18/08/17 PRICE SENSITIVE download Created with Sketch. 114.22KB Share SNT Preliminary Final Report June 2017 11/08/17 PRICE SENSITIVE download Created with Sketch. 689.39KB Share SNT Appendix 4C - quarterly June 2017 28/07/17 PRICE SENSITIVE download Created with Sketch. 122.02KB Share SNT Pharmaxis Announces Results of Pivotal CF Clinical Trial 13/06/17 PRICE SENSITIVE download Created with Sketch. 138.27KB Share SNT Pharmaxis Set to Generate Further Euro 10m Milestone Payment 15/05/17 PRICE SENSITIVE download Created with Sketch. 123.08KB Share SNT Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy 08/05/17 PRICE SENSITIVE download Created with Sketch. 117.46KB Share SNT Appendix 4C - quarterly cash flow 18/04/17 PRICE SENSITIVE download Created with Sketch. 121.95KB Share SNT Quarterly Shareholder Update March 2017 18/04/17 PRICE SENSITIVE download Created with Sketch. 370.26KB Share SNT Synairgen Collaboration Progress 13/03/17 PRICE SENSITIVE download Created with Sketch. 477.69KB Share SNT Half Yearly Report and Accounts 17/02/17 PRICE SENSITIVE download Created with Sketch. 187.68KB Share SNT Appendix 4C - quarterly 30/01/17 PRICE SENSITIVE download Created with Sketch. 98.28KB Share SNT Chairman's Address to Shareholders 29/11/16 PRICE SENSITIVE download Created with Sketch. 108.08KB Share SNT Research Collaboration with Woolcock Institute 15/11/16 PRICE SENSITIVE download Created with Sketch. 126.95KB Share SNT Appendix 4C - quarterly-PXS.AX 28/10/16 PRICE SENSITIVE download Created with Sketch. 98.17KB Share SNT Pharmaxis Announces Russian Approval for Bronchitol-PXS.AX 27/09/16 PRICE SENSITIVE download Created with Sketch. 127.16KB Share SNT Preliminary Final Report-PXS.AX 19/08/16 PRICE SENSITIVE download Created with Sketch. 619.57KB Share SNT Appendix 4C - quarterly-PXS.AX 29/07/16 PRICE SENSITIVE download Created with Sketch. 98.6KB Share SNT Pharmaxis Completes Recruitment of CF Clinical Trial for US-PXS.AX 15/07/16 PRICE SENSITIVE download Created with Sketch. 145.98KB Share SNT Appendix 4C - quarterly March 2016-PXS.AX 14/04/16 PRICE SENSITIVE download Created with Sketch. 98.55KB Share SNT Synairgen Collaboration Progress 23/03/16 PRICE SENSITIVE download Created with Sketch. 470.5KB Share SNT Half Yearly Report and Accounts 26/02/16 PRICE SENSITIVE download Created with Sketch. 189.89KB Share SNT Quarterly Share Update - December 2015 29/01/16 PRICE SENSITIVE download Created with Sketch. 154.61KB Share SNT Appendix 4C - quarterly 29/01/16 PRICE SENSITIVE download Created with Sketch. 98.55KB Share SNT Bronchitol Paediatric CF Trial Reports Postive Results 16/12/15 PRICE SENSITIVE download Created with Sketch. 141.42KB Share SNT Appendix 4C - quarterly 23/10/15 PRICE SENSITIVE download Created with Sketch. 98.32KB Share SNT PXS Releases Successful Phase Results of Phase 1 Trial 22/09/15 PRICE SENSITIVE download Created with Sketch. 123.66KB Share SNT Preliminary Final Report 19/08/15 PRICE SENSITIVE download Created with Sketch. 738.56KB Share SNT Pharmaxis and Synairgen Announce Research Collaboration 05/08/15 PRICE SENSITIVE download Created with Sketch. 156.66KB Share SNT Appendix 4C - quarterly 31/07/15 PRICE SENSITIVE download Created with Sketch. 102.18KB Share SNT PXS Announces Completion of Restructuring and New Focus 19/05/15 PRICE SENSITIVE download Created with Sketch. 112.35KB Share SNT Boehringer Ingelheim acquires Pharmaxis phase 1 drug 18/05/15 PRICE SENSITIVE download Created with Sketch. 141.54KB Share SNT Pharmaxis Signs Second Agreement with Chiesi 08/05/15 PRICE SENSITIVE download Created with Sketch. 123.32KB Share SNT Appendix 4C - quarterly cash flow 17/04/15 PRICE SENSITIVE download Created with Sketch. 100.22KB Share SNT Interim Results of Phase 1 Clinical Trial for PXS4728A 07/04/15 PRICE SENSITIVE download Created with Sketch. 119.37KB Share SNT Pharmaxis Signs with Boehringer Ingelheim for PXS4728A 12/03/15 PRICE SENSITIVE download Created with Sketch. 131.72KB Share SNT Half Yearly Report and Accounts 26/02/15 PRICE SENSITIVE download Created with Sketch. 221.79KB Share SNT Appendix 4C - quarterly 30/01/15 PRICE SENSITIVE download Created with Sketch. 100.17KB Share SNT Commencement of Phase 1 Clinical Trial for SSAO Inhibitor 21/01/15 PRICE SENSITIVE download Created with Sketch. 123.8KB Share SNT Commercialisation in US and NovaQuest Dispute Settled 24/12/14 PRICE SENSITIVE download Created with Sketch. 161.92KB Share SNT Appendix 4C - quarterly 30/10/14 PRICE SENSITIVE download Created with Sketch. 103.11KB Share SNT Phase 3 Clinical Trial in Cystic Fibrosis 30/10/14 PRICE SENSITIVE download Created with Sketch. 157.79KB Share SNT New data from B305 clinical trial presented at ERS 08/09/14 PRICE SENSITIVE download Created with Sketch. 129.29KB Share SNT Preliminary Final Report, Financial and Directors' Report 28/08/14 PRICE SENSITIVE download Created with Sketch. 861.79KB Share SNT SSAO Inhibitor Ready for the Clinic 28/08/14 PRICE SENSITIVE download Created with Sketch. 108.14KB Share SNT Pharmaxis Files Lawsuit Against NovaQuest 04/08/14 PRICE SENSITIVE download Created with Sketch. 119.2KB Share SNT Appendix 4C - quarterly 30/07/14 PRICE SENSITIVE download Created with Sketch. 102.63KB Share SNT Update On Timing Of Pre-Clinical Partnering Projects 08/07/14 PRICE SENSITIVE download Created with Sketch. 118.96KB Share SNT Communication from Financier NovaQuest 08/07/14 PRICE SENSITIVE download Created with Sketch. 127.52KB Share SNT Trading Halt 04/07/14 PRICE SENSITIVE download Created with Sketch. 60.56KB Share SNT Appendix 4C - quarterly 16/04/14 PRICE SENSITIVE download Created with Sketch. 102.78KB Share SNT Half Yearly Report and Accounts 19/02/14 PRICE SENSITIVE download Created with Sketch. 266.5KB Share SNT Appendix 4C - quarterly 30/01/14 PRICE SENSITIVE download Created with Sketch. 136.29KB Share SNT Scottish Medicines Consortium Accepts Bronchitol for CF Use 10/12/13 PRICE SENSITIVE download Created with Sketch. 111.59KB Share SNT Pharmaxis Elects to Receive Full NovaQuest Investment 30/10/13 PRICE SENSITIVE download Created with Sketch. 109.35KB Share SNT Appendix 4C - quarterly 16/10/13 PRICE SENSITIVE download Created with Sketch. 101.93KB Share SNT Pharmaxis Announces Delay to French Pricing for Bronchitol 29/08/13 PRICE SENSITIVE download Created with Sketch. 117.25KB Share SNT Preliminary Final Report 15/08/13 PRICE SENSITIVE download Created with Sketch. 417.76KB Share SNT PHARMAXIS ANNOUNCES IMPROVED PBS LISTING OF BRONCHITOL 18/07/13 PRICE SENSITIVE download Created with Sketch. 109.09KB Share SNT Appendix 4C - quarterly 17/07/13 PRICE SENSITIVE download Created with Sketch. 102.19KB Share SNT Pharmaxis Awarded Two ARC Linkage Grants 05/07/13 PRICE SENSITIVE download Created with Sketch. 125.75KB Share SNT European CF Clinical Trial in Paediatric Patients Begins 20/06/13 PRICE SENSITIVE download Created with Sketch. 126.62KB Share
(20min delay)
